[1]窦香君,王治静,杨 乐.儿童难治性癫痫采用生酮饮食治疗对血脂水平影响的研究分析[J].现代检验医学杂志,2022,37(06):188-191+204.[doi:10.3969/j.issn.1671-7414.2022.06.036]
　DOU Xiang-jun,WANG Zhi-jing,YANG Le.Effect of Ketogenic Diet on Serum Lipid Levels in Children with Refractory Epilepsy[J].Journal of Modern Laboratory Medicine,2022,37(06):188-191+204.[doi:10.3969/j.issn.1671-7414.2022.06.036]
点击复制

儿童难治性癫痫采用生酮饮食治疗对血脂水平影响的研究分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年06期
页码:
188-191+204
栏目:
检验与临床
出版日期:
2022-11-15

文章信息/Info

Title:
Effect of Ketogenic Diet on Serum Lipid Levels in Children with Refractory Epilepsy
文章编号:
1671-7414(2022)06-188-05
作者:
窦香君; 王治静; 杨 乐
(西安市儿童医院神经内科, 西安 710002)
Author(s):
DOU Xiang-jun;  WANG Zhi-jing;  YANG Le
(Department of Pediatric Neurology, Xi’an Children’ Hospital, Xi’an 710002, China)
关键词:
儿童难治性癫痫; 生酮饮食; 血脂
分类号:
R742.1；R446，112
DOI:
10.3969/j.issn.1671-7414.2022.06.036
文献标志码:
A
摘要:
目的 评估经典生酮饮食(ketogenic diet, KD)治疗儿童难治性癫痫过程中对血脂水平的影响。方法 回顾性收集2016 年1 月~2020 年6 月在西安市儿童医院神经内科接受KD 添加治疗的药物难治性癫痫患儿54 例，其中男性39 例(72.2 %)，女性15 例(27.8 %)。所有纳入病例均至少接受KD 治疗三个月，且不管终止KD 治疗的时间点，比较KD 治疗前、KD 治疗1，3，6，12 个月末血清中总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL) 及三酰甘油(TG) 水平变化，进行相应统计学分析，P ＜ 0.05 为差异具有统计学意义。结果 54 例接受KD 治疗的药物难治性癫痫患儿被纳入研究，采用单因素重复测量方差分析及Bonferroni 检验两两比较发现，血清TC，TG，LDL 平均水平在KD 治疗1，3，6 个月末均明显升高，差异有统计学意义(F =14.655，10.980，20.292，均P ＜ 0.001)，在KD 治疗三月后出现高脂血症的患儿比例最高，此后该比例逐渐下降。根据接受KD 治疗时长，将患儿分为三组：3 ～ 6 个月(第1 组，n=23)，6 ～ 12 月(第2 组，n=22)和＞ 12 月(第3 组，n=9)，采用单因素方差分析及Games-Howell 检验两两比较发现，在接受KD 治疗6 个月末，第1 组病例患儿的LDL 平均水平低于第2 组和第3 组病例患儿，差异有统计学意义(F=3.532，P=0.037)，而第2 组和第3 组病例患儿的LDL 平均水平比较差异无统计学意义(P ＞ 0.05)。此外，不同分组的病例患儿TC，TG 及HDL 平均水平比较差异均无统计学意义(P ＞ 0.05)。结论 经典高脂肪比例 KD 治疗可导致患儿TC, TG 和LDL 水平明显升高，且在治疗三个月后出现血脂异常患儿比例最高，但大部分在停止KD 治疗或饮食干预后可逐渐恢复正常。
Abstract:
Objective To evaluate the effect of ketogenic diet(KD) on serum lipid levels in children with refractory epilepsy. Methods This retrospective study enrolled 54 patients，including 39 males (72.2%) and 15 females (27.8%)，with drug resistant epilepsy treated with KD at Deparment of Neurology, Xi’an Children’s Hospital, between January 2016 and June 2020. All included patients received KD treatment for at least 3 months, regardless of the time point of termination of KD treatment, at baseline and post-treatment 1, 3, 6, and 12 months, total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglyceride (TG) levels were measured and compared, P < 0.05 were considered to be statistically significant. Results 54 children with drugresistant epilepsy receiving KD were included in the study, using Mean total TC, TG and LDL levels were significantly higher at 1st, 3rd and 6th months of the KD treatment compared to baseline levels (F= 14.655, 20.292, 10.980, P<0.001), using univariate repeated measures analysis of variance and Bonferroni test, the differences were statistically significant. The ratio of the patients who developed dyslipidemia was highest at 3rd month of the KD treatment, and decreased after that. Patients were divided in three groups based on duration between KD initiation and discontinuation: 3 ~6 months(group 1，n=23)，6~12 months(group 2，n=22) and >12 months(group 3，n=9). One-way ANOVA was performed to analyse the lipid differences among the three above groups. To identify the source of significant differences among means, post hoc analysis was performed using the Games-Howell test. The mean LDL levels of patients in the group 1 were lower at 6th months post KD, compared to those were in the group 2 and group 3, the difference was statistically significant (F=3.532, P=0.037), but no significant difference of mean LDL levels was found between the groups 2 and 3. In addition，the mean levels of TC, TG and HDL among the three groups were not significant different(P>0.05).Conclusion Classical highfat ratio KD treatment can lead to significant increase of TC,TG and LDL levels in patients. The proportion of patients with dyslipidemia was the highest at three months of the KD treatment, but most of them gradually recovered after discontinuation of KD treatment or interventions.

参考文献/References:

[1] AABERG K M, ERIKSSON A S, RAMM-PETTERSEN J, et al. Long-term outcome of resective epilepsy surgery in Norwegian children[J].Acta Paediatr, 2012 , 101(12):e557- e 560.
[2] CAMFIELD P, CAMFIELD C. Incidence, prevalence and aetiology of seizures and epilepsy in children [J]. Epileptic Disord, 2015, 17(2):117-123.
[3] VIDALI S, AMINZADEH S, LAMBERT B, et al. Mitochondria: The ketogenic diet-A metabolism-based therapy [J]. Int J Biochem Cell Biol, 2015 , 63:55-9.
[4] GUZEL O, UYSAL U, ARSLAN N. Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: A single center experience from Turkey[J]. Eur J Paediatr Neurol, 2019, 23(1):143-151.
[5] BABY N, VINAYAN K P, PAVITHRAN N, et al. A pragmatic study on e?cacy, tolerability and long term acceptance of ketogenic diet therapy in 74 South Indian children with pharmacoresistant epilepsy[J]. Seizure, 2018 , 58:41-46.
[6] 中华医学会儿科学分会神经学组生酮饮食疗法协作组 . 长期生酮饮食治疗儿童难治性癫痫的前瞻性多中心研究 [J].中华儿科杂志 ,2013,51 (4): 276-282. Ketogenic Diet Study Group of the Subspecialty Group of Neurology, the Society of Pediatrics, Chinese Medical Association. Prospective multicenter study on long-term ketogenic diet therapy for intractable childhood epilepsy [J] . Chinese Journal of Pediatrics,2013,51 (4): 276-282.
[7] NEAL E G, CHAFFE H, SCHWARTZ R H, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial[J]. Lancet Neurol, 2008, 7(6):500-506.
[8] LEFEVRE F, ARONSON N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy[J]. Pediatrics, 2000, 105(4):E46.
[9] 周水珍 ,郁莉斐 .规范生酮饮食在儿童神经系统疾病中的应用与管理 [J].中华儿科杂志 , 2019,57(11):817-819. ZHOU Shuizhen, YU Lifei. Standardizing the ap-plication and management of ketogenic diet in ner-vous system diseases[J], Chinese Journal of Pediat-rics,2019,57(11):817-819.
[10] G?ZEL O, YILMAZ U, UYSAL U, et al. The effect of olive oil-based ketogenic diet on serum lipid levels in epileptic children[J]. Neurol Sci, 2016, 37(3):465-470.
[11] NIZAMUDDIN J, TURNER Z, RUBENSTEIN J E, et al.Management and risk factors for dyslipidemia with the ketogenic diet [J]. J Child Neurol, 2008, 23(7):758-761.
[12] KOSSOFF E H, ZUPEC-KANIA B A, AUVIN S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommenda-tions of the international ketogenic diet study group[J]. Epilepsia Open, 2018 , 3(2):175-192.
[13] GROESBECK D K, BLUML R M. KOSSOFF E H. Long-term use of the ketogenic diet in the treatment of epilepsy[J].Developmental Medicine and Child Neurology, 2006,48(12):978-981.
[14] KWITEROVICH P O, VINING E P, PYZIK P, et al. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children[J]. JAMA, 2003 , 290(7):912-920.
[15] PE?ALVO J L, OLIVA B, SOTOS-PRIETO M, et al. Greater adherence to a Mediterranean dietary pattern is associated with improved plasma lipid profile: the Aragon Health Workers Study cohort[J]. Rev Esp Cardiol (Engl Ed), 2015, 68(4):290-297.
[16] PAOLI A, CENCI L, GRIMALDI K A. Effect of ketogenic Mediterranean diet with phytoextracts and low carbohydrates/high-protein meals on weight, cardiovascular risk factors, body composition and diet compliance in Italian council employees[J]. Nutr J, 2011, 10:112.
[17] LIU Y M, LOWE H, ZAK M M, et al. Can children with hyperlipidemia receive ketogenic diet for medication-resistant epilepsy[J]. J Child Neurol, 2013, 28(4):479-483.
[18] LIMA P A, DE BRITO SAMPAIO L P, DAMASCENO N R. Ketogenic diet in epileptic children: impact on lipoproteins and oxidative stress[J]. Nutr Neurosci, 2015, 18(8):337-344.
[19] CERVENKA M C, PATTON K, ELOYAN A, et al. The impact of the modified Atkins diet on lipid profiles in adults with epilepsy[J]. Nutr Neurosci, 2016, 19(3):131-137.

备注/Memo

备注/Memo:
基金项目：陕西省科技厅资助项目，项目编号2021JM-559。
作者简介：窦香君(1987-)，女，硕士研究生，主治医师，专业：儿童神经系统疾病，E-mail：douxiangjun@126.com。
通讯作者：杨乐(1987-)，女，硕士研究生，主治医师，专业：儿童神经系统疾病，E-mail：leyangsjk@163.com。
更新日期/Last Update: 2022-11-15